Interpace Biosciences Announces Second Quarter 2021 Financial and Business Results
10 août 2021 16h05 HE
|
Interpace Biosciences, Inc.
●Q2 Revenue of $11.2 Million Surpasses Q1 2021 as Company’s Highest Revenue Quarter ●Company approaching EBITDA breakeven on Higher Clinical Volume, Revenue, Improved Gross Profit and Operating...
Beyond Celiac Expands Board in Drive Toward a Cure
15 juil. 2021 14h53 HE
|
Beyond Celiac
Philadelphia, PA, July 15, 2021 (GLOBE NEWSWIRE) -- Beyond Celiac, the leading catalyst for a celiac disease cure in the United States, announced today that Lisa Agdern, executive director,...
Beyond Celiac and National Minority Quality Forum to Co-Present at Prestigious DIA 2021 Life Sciences Event
24 juin 2021 15h17 HE
|
Beyond Celiac
Philadelphia, PA, June 24, 2021 (GLOBE NEWSWIRE) -- Beyond Celiac, the leading catalyst for a celiac disease cure in the United States, is honored to be presenting at the upcoming DIA 2021 Global...
US Capital Global Securities Launches $10MM Convertible Note Offering for QT Imaging, Inc.
18 mars 2021 07h09 HE
|
US Capital Global
San Francisco, California, March 18, 2021 (GLOBE NEWSWIRE) -- US Capital Global Securities LLC, an affiliate of US Capital Global, is offering to eligible investors an investment opportunity of up...
Interpace Biosciences Announces Impending Delisting from Nasdaq
17 févr. 2021 08h00 HE
|
Interpace Biosciences, Inc.
PARSIPPANY, NJ, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (NASDAQ: IDXG) (“Interpace” or the “Company”), a leader in enabling personalized medicine, today announced that on...
Interpace Biosciences Announces License Agreement with Rutgers University and Mass General Hospital
01 févr. 2021 09h27 HE
|
Interpace Biosciences, Inc.
Parsippany, NJ, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (Nasdaq: IDXG) announced today that it has executed a license agreement with Rutgers, The State University of New...
ProPhase Labs Announces Opening of Large CLIA Lab Covid Testing Facility in Garden City, New York
29 janv. 2021 08h30 HE
|
ProPhase Labs, Inc.
- Total Company Processing Capacity On Track to Reach 60,000 Tests Per Day – GARDEN CITY, NY, Jan. 29, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical...
Beyond Celiac Joins Forces with National Minority Quality Forum to Target Inequities in Celiac Disease Diagnosis, Treatment
27 oct. 2020 09h20 HE
|
Beyond Celiac
Philadelphia, PA, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Beyond Celiac, the leading patient organization and catalyst for a celiac disease cure in the U.S., and the National Minority Quality Forum...
Author Saves Lives by Sharing Advice on Living with Lupus
18 août 2020 15h12 HE
|
WestBow Press
FARMERS BRANCH, TX, Aug. 18, 2020 (GLOBE NEWSWIRE) -- God had a plan for Dr. LaTonya Bias, but her faith was tested when she was diagnosed with Lupus years ago. Grief, depression, isolation, and...
Interpace Biosciences to Host Conference Call and Webcast to Discuss First Quarter, 2020 Financial Results on Thursday June 25, 2020
24 juin 2020 16h20 HE
|
Interpace Biosciences, Inc.
PARSIPPANY, NJ, June 24, 2020 (GLOBE NEWSWIRE) -- Interpace Biosciences (IDXG) announced today that it will report its first quarter, 2020 financial results on Thursday, June 25, 2020 at 4:30 p.m....